IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

Journal of Clinical Investigation

Volumn 101, Issue 2, 1998, Pages 311-320

  Xing, Zhou ^a   Gauldie, Jack ^a   Cox, Gerard ^a   Baumann, Heinz ^b   Jordana, Manel ^a   Lei, Xue Feng ^a   Achong, Michelle K ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cytokines; Endotoxin; Inflammation; Lung; Neutrophils

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; ESCHERICHIA COLI ENDOTOXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; RECOMBINANT INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; LUNG LAVAGE; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032518415     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1368     Document Type: Article

References (40)

1. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 258:593-597.
2. Zitnik, R.J., and J.A. Elias. 1993. Interleukin-6 and the lung. In Cytokines of the Lung. J. Kelly, editor. Marcel Dekker, Inc. New York. 229-280.
3. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunol. Today. 15:74-80.
4. Xing, Z., C.D. Richards, T. Braciak, V. Thibault, and J. Gauldie. 1995. Cytokine regulation of hepatic acute phase protein expression. In Cytokines and the Liver, Falk Symposium 78. W. Gerok, K. Decker, T. Andus, and V. Gross, editors. Kluwer Academic Publishers Group, Dordrecht, Netherlands. 164-171.
5. Starnes, H.F., M.K. Pearce, A. Tewari, J.H. Yim, J.-C. Zou, and J.S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J. Immunol. 145:4185-4191.
6. Heremans, H., C. Dillen, W. Put, J.V. Damme, and A. Billiau. 1992. Protective effect of anti-interleukin-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels. Eur. J. Immunol. 22:2395-2401.
7. Barton, B.E., and J.V. Jackson. 1993. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61: 1496-1499.
8. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bleuthmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:339-342.
9. Xing, Z., Y. Ohkawara, M. Jordana, F.L. Graham, and J. Gauldie. 1997. Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther. 4:140-149.
10. Cox, G., J. Crossley, and Z. Xing. 1995. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am. J. Respir. Cell Mol. Biol. 12:232-237.
11. Xing, Z., Y. Ohkawara, M. Jordana, F.L. Graham, and J. Gauldie. 1996. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97: 1102-1110.
12. Xing, Z., T. Braciak, M. Jordana, K. Croitoru, F.L. Graham, and J. Gauldie. 1994. Adenovirus-mediated cytokine gene transfer at tissue sites: overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J. Immunol. 153:4059-4069.
13. Xing, Z., M. Jordana, T. Braciak, T. Ohtoshi, and J. Gauldie. 1993. Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Am. J. Respir. Cell Mol. Biol. 9:255-263.
14. Xing, Z., M. Jordana, H. Kirpalani, K.E. Driscoll, T.J. Schall, and J. Gauldie. 1994. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces TNF-alpha, MIP-2, IL-1beta, and IL-6 but not RANTES or TGF betal mRNA expression in acute lung inflammation. Am. J. Respir. Cell Mol. Biol. 10:148-153.
15. Kelley, J. 1993. Transforming growth factor-ß. In Cytokine of the Lung. J. Kelley, editor. Marcel Dekker, Inc. New York. 101-137.
16. Ulich, T.R., S. Yin, K. Guo, E.S. Yi, D. Remick, and J. del Castillo. 1991. Intractracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol. 138: 1097-1101.
17. Ulich, T.R., L.R. Watson, S. Yin, K. Guo, P. Wang, H. Thang, and J. del Castillo. 1991. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138:1485-1496.
18. Shellito, J.E., J.K. Kolls, and W.R. Summer. 1995. Regulation of nitric oxide release by macrophages after intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 13:45-53.
19. Schmal, H., T.P. Shanley, M.L. Jones, H.P. Friedl, and P.A. Ward. 1996. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 156:1963-1970.
20. Afford, S.C., J. Pongracz, R.A. Stockley, J. Crocker, and D. Burnett. 1992. The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J. Biol. Chem. 267:21612-21616.
21. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, C. Toniatti, P. Puccetti, F. Bistoni, and V. Poli. 1996. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345-1355.
22. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1243-1250.
23. Ruzek, M.C., A.M. Miller, S.M. Opal, B.D. Pearce, and C.A. Biron. 1997. Characterization of early cytokine responses and an interleukin-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185:1185-1192.
24. Gupta, S., L. Feng, T. Yoshimura, J. Redick, S.-M. Fu, and C.E. Rose. 1996. Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am. J. Respir. Cell Mol. Biol. 15:656-663.
25. Ulich, T.R. 1993. Tumor necrosis factor. In Cytokine of the Lung. J. Kelley, editor. Marcel Dekker, Inc. New York. 307-330.
26. Bundschuh, D.S., J. Barsig, T. Hartung, F. Randow, W.-D. Docke, H.-D. Volk, and A. Wendel. 1997. Granulocyte-macrophage colony-stimulating factor and INF gamma restore the systemic TNF alpha response to endotoxin in lipopolysaccharide-desensitized mice. J. Immunol. 158:2862-2871.
27. Standiford, T.J., R.M. Strieter, N.W. Lukas, and S.L. Kunkel. 1995. Neutrolization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155:2222-2229.
28. Manthey, C.L., and S.N. Vogel. The role of cytokines in host responses to endotoxin. 1992. Rev. Med. Microbiol. 3:72-79.
29. Waring, P.M., L.J. Waring, T. Billington, and D. Metcalf. 1995. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc. Natl. Acad. Sci. USA. 92:1337-1341.
30. Howard, M.A., A. O'Garra, H. Ishida, R. de Waal Malefyt, and J. de Vries. 1992. Biological properties of interleukin 10. J. Clin. Immunol. 12:239.
31. Greenberger, M.J., R.M. Strieter, S.L. Kunkel, J.M. Danforth, R.E. Goodman, and T.J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of klebsiela pneumonia. J. Immunol. 155:722-729.
32. Tilg, H., E. Trehu, M.B. Atkins, C.A. Dinarello, and J.W. Mier. 1994. Interleukin-6 as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 83: 113-118.
33. Aderka, D., J. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice. J. Immunol. 143:3517-3523.
34. Ulich, T.R., K. Guo, D. Remick, J. del Castillo, and S. Yin. 1991. Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J. Immunol. 146: 2316-2323.
35. Ramsay, A.J., A.J. Husband, I.A. Ramshaw, S. Bao, K.I. Matthaei, G. Koehler, and M. Kopt. 1994. The role of IL-6 in mucosal IgA antibody responses in vivo. Science. 264:561-563.
36. Mule, J.J., M.C. Custer, W.D. Travis, and S.A. Rosenberg. 1992. Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. J. Immunol. 148:2622-2629.
37. Llorente, L., W. Zou, Y. Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J.-C. Brouet, D. Alarcon-Segovia, P. Galanaud, and D. Emilie. 1995. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839-844.
38. Giovarelli, M., P. Musiani, A. Modesti, P. Dellabona, G. Casorati, A. Allione, M. Consalvo, F. Cavallo, F. di Pierro, C. De Giovanni, et al. 1995. Local release of IL-10 by transtected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol. 155:3112-3123.
39. Lotz, M., and P.-A. Guerne. 1991. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 266:2017-2020.
40. Richards, C.D., M. Shoyab, T.J. Brown, and J. Gauldie. 1993. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol. 150:5596-5603.